National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$54.00
add to cart

Rights & Permissions

Related Titles

topleft topright

Environmental Medicine: Integrating a Missing Element into Medical Education (1995)
Institute of Medicine (IOM)

Citation Manager

. "Case Study 43: Occupational Asthma Due to Toluene Diisocyanate Among Velcro-like Tape Manufacturers." Environmental Medicine: Integrating a Missing Element into Medical Education. Washington, DC: The National Academies Press, 1995.

Please select a format:

BibTeX EndNote RefMan


Page
744
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Environmental Medicine: Integrating a Missing Element into Medical Education

Occupational Asthma Due to Toluene Diisocyanate Among Velcro-Like Tape Manufacturers

Jung-Der Wang, MD, ScD, Ping-Hung Huang, MD, Jia-Ming Lin, PhD, Shyh-Young Su, BS, and Min-Chien Wu, MD

During September-November, 1985, four employees of a factory were seen at the occupational clinic complaining of cough, shortness of breath, and wheezing. All four worked in the same area of the factory where an adhesive containing toluene diisocyanate (TDI) was applied to velcro-like tape during manufacturing. To confirm the diagnosis of TDI-induced asthma and determine the prevalence among workers, 38 workers were interviewed and examined (84%) in the factory. Air samples were also taken from several areas in the factory to determine the TDI concentration. For analysis, the factory was divided into three areas based on the concentration of TDI: low (0.012±0.002 ppm), medium (0.021±0.006 ppm), and high (0.047±0.054 ppm). The distribution of workers with symptoms of asthmatic bronchitis was highly associated with TDI concentration (p<0.001). After stopping work for a period of 10 days, workers in areas with a high concentration of TDI showed marked improvement in pulmonary function tests (PFTs). After isolation of the exposure site, improvement of the ventilation system, and substitution of the TDI with less volatile diphenylmethane diisocyanate (MDI), air concentration of isocyanates was usually below 0.007 ppm. Three of the four clinically overt asthma cases went back to work without any difficulty. The PFTs of affected workers showed a significant improvement 5 months later. We conclude that TDI was responsible for the occupational asthma among velcro-like tape manufacturers and that the TDI-induced impairment of pulmonary functions was at least partially reversible.

Key words: TDI, asthma, isocyanates, MDI

INTRODUCTION

During September-November, 1985, four employees of a factory in Taipei County were seen in an outpatient clinic of the National Taiwan University Hospital complaining of cough, shortness of breath, chest tightness, and wheezing. The symptoms tended to be worse at night and improved after long holidays. All four employees worked in the same area in the factory where an adhesive was applied to the velcro-like tape during the manufacturing process. A review of all the processes

   

Graduate Institute of Public Health and Department of Internal Medicine, National Taiwan University, College of Medicine.

Address reprint requests to Dr. Jung-Der Wang, Graduate Institute of Public Health, National Taiwan

University, College of Medicine No. 1, Section 1, Jen-Ai Road, Taipei, Taiwan, R.O.C. (10018).

Accepted for publication December 22, 1987.

© 1988 Alan R.Liss, Inc.

Reprinted with permission from American Journal of Industrial Medicine 14(1):73–8, Copyright 1988, Alan R. Liss, Inc.

Page
744
Front Matter (R1-R12)
Executive Summary (1-4)
1 Introduction (5-13)
2 Curriculum Content (14-21)
3 Implementation Strategies (22-43)
4 Changing Medical Education (44-51)
5 Concluding Remarks (52-53)
References (54-58)
Appendixes (59-60)
A: Taking an Exposure History (61-96)
B: Medical School Courses and Clerkships: Access Points for Integrating Environmental Medicine (97-120)
C: Case Studies in Environmental Medicine (121-138)
Case Study 1: Arsenic Toxicity (139-163)
Case Study 2: Seasonal Arsenic Exposure from Burning Chromium-Copper-Arsenate-Treated Wood (164-167)
Case Study 3: Asbestos Toxicity (168-188)
Case Study 4: Benzene Toxicity (189-207)
Case Study 5: Beryllium Toxicity (208-223)
Case Study 6: Cadmium Toxicity (224-243)
Case Study 7: Fetal Death Due to Nonlethal Maternal Carbon Monoxide Poisoning (244-248)
Case Study 8: Carbon Tetrachloride Toxicity (249-266)
Case Study 9: Chlordane Toxicity (267-288)
Case Study 10: Chronic Reactive Airway Disease Following Acute Chlorine Gas Exposure in an Asymptomatic Atopic Patient (289-290)
Case Study 11: Chromium Toxicity (291-311)
Case Study 12: Cyanide Toxicity (312-331)
Case Study 13: Dioxin Toxicity (332-348)
Case Study 14: Ethylene/Propylene Glycol Toxicity (349-371)
Case Study 15: Formalin Asthma in Hospital Staff (372-373)
Case Study 16: Gasoline Toxicity (374-394)
Case Study 17: Hantavirus Pulmonary Syndrome: A Clinical Description of 17 Patients with a Newly Recognized Disease (395-401)
Case Study 18: Lead Poisoning from Mobilization of Bone Stores During Thyrotoxicosis (402-409)
Case Study 19: Lead Toxicity (410-435)
Case Study 20: Legionaires' Disease: Description of an Epidemic of Pneumonia (436-444)
Case Study 21: Mercury in House Paint as a Cause of Acrodynia: Effect of Therapy with N-Acetyl-D, L-Penixillamine (445-449)
Case Study 22: Mercury Toxicity (450-472)
Case Study 23: Methanol Toxicity (473-492)
Case Study 24: Methylene Chloride Toxicity (493-511)
Case Study 25: Paint Remover Hazard (512-515)
Case Study 26: Fatal Outcome of Methemoglobinemia in an Infant (516-517)
Case Study 27: Nitrate/Nitrite Toxicity (518-537)
Case Study 28: An Outbreak of Nitrogen Dioxide-Induced Respiratory Illness Among Ice Hockey Players (538-541)
Case Study 29: Pentachlorophenol Toxicity (542-557)
Case Study 30: Aldicarb Poisoning: A Case Report with Prolonged Cholinesterase Inhibition and Improvement After Pralidoxime Therapy (558-561)
Case Study 31: Cholinesterase-Inhibiting Pesticide Toxicity (562-584)
Case Study 32: Infertility in Male Pesticide Workers (585-587)
Case Study 33: Pesticide Food Poisoning from Contaminated Watermelons in California, 1985 (588-595)
Case Study 34: Poisoning of an Urban Family Due to Misapplication of Household Organophosphate and Carbamate Pesticides (596-604)
Case Study 35: Polynuclear Aromatic Hydrocarbon (PAH) Toxicity (605-621)
Case Study 36: Polychlorinated Biphenyl (PCB) Toxicity (622-638)
Case Study 37: Ionizing Radiation (639-673)
Case Study 38: Radon Toxicity (674-694)
Case Study 39: Residential Radon Exposure and Lung Cancer in Sweden (695-700)
Case Study 40: Community Oubreaks of Asthma Associated with Inhalation of Soybean Dust (701-706)
Case Study 41: Tetrachloroethylene Toxicity (707-726)
Case Study 42: Toluene Toxicity (727-743)
Case Study 43: Occupational Asthma Due to Toluene Diisocyanate Among Velcro-like Tape Manufacturers (744-749)
Case Study 44: 1,1,1-Trichloroethane (750-766)
Case Study 45: Trimethyltin Encephalopathy (767-771)
Case Study 46: Trichloroethylene Toxicity (772-792)
Case Study 47: Vinyl Chloride Toxicity (793-811)
Case Study 48: Work-Related Disorders of the Neck and Upper Extremity (812-813)
Case Study 49: Contact Dermatitis in Surgeons from Methylmethacrylate Bone Cement (814-816)
Case Study 50: Skin Lesions and Environmental Exposures: Rash Decisions (817-861)
Case Study 51: Acoustic Trauma Caused by the Telephone: A Report of Two Cases (862-867)
Case Study 52: Behavioral and Audiologic Manifestations of Noise-Induced Hearing Loss (868-871)
Case Study 53: Reproductive and Developmental Hazards (872-892)
Case Study 54: Childhood Asthma and Indoor Enviromental Risk Factors (893-903)
Case Study 55: Populations at Risk From Particulate Air Pollution - United States, 1992 (904-908)
D: Resources: Agencies, Organizations, Services, REferences, and Tables of Environmental Health Hazards (909-970)
E: Committee and Staff Biographies (971-975)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 744
Environmental Medicine: Integrating a Missing Element into Medical Education Occupational Asthma Due to Toluene Diisocyanate Among Velcro-Like Tape Manufacturers Jung-Der Wang, MD, ScD, Ping-Hung Huang, MD, Jia-Ming Lin, PhD, Shyh-Young Su, BS, and Min-Chien Wu, MD During September-November, 1985, four employees of a factory were seen at the occupational clinic complaining of cough, shortness of breath, and wheezing. All four worked in the same area of the factory where an adhesive containing toluene diisocyanate (TDI) was applied to velcro-like tape during manufacturing. To confirm the diagnosis of TDI-induced asthma and determine the prevalence among workers, 38 workers were interviewed and examined (84%) in the factory. Air samples were also taken from several areas in the factory to determine the TDI concentration. For analysis, the factory was divided into three areas based on the concentration of TDI: low (0.012±0.002 ppm), medium (0.021±0.006 ppm), and high (0.047±0.054 ppm). The distribution of workers with symptoms of asthmatic bronchitis was highly associated with TDI concentration (p<0.001). After stopping work for a period of 10 days, workers in areas with a high concentration of TDI showed marked improvement in pulmonary function tests (PFTs). After isolation of the exposure site, improvement of the ventilation system, and substitution of the TDI with less volatile diphenylmethane diisocyanate (MDI), air concentration of isocyanates was usually below 0.007 ppm. Three of the four clinically overt asthma cases went back to work without any difficulty. The PFTs of affected workers showed a significant improvement 5 months later. We conclude that TDI was responsible for the occupational asthma among velcro-like tape manufacturers and that the TDI-induced impairment of pulmonary functions was at least partially reversible. Key words: TDI, asthma, isocyanates, MDI INTRODUCTION During September-November, 1985, four employees of a factory in Taipei County were seen in an outpatient clinic of the National Taiwan University Hospital complaining of cough, shortness of breath, chest tightness, and wheezing. The symptoms tended to be worse at night and improved after long holidays. All four employees worked in the same area in the factory where an adhesive was applied to the velcro-like tape during the manufacturing process. A review of all the processes     Graduate Institute of Public Health and Department of Internal Medicine, National Taiwan University, College of Medicine. Address reprint requests to Dr. Jung-Der Wang, Graduate Institute of Public Health, National Taiwan University, College of Medicine No. 1, Section 1, Jen-Ai Road, Taipei, Taiwan, R.O.C. (10018). Accepted for publication December 22, 1987. © 1988 Alan R.Liss, Inc. Reprinted with permission from American Journal of Industrial Medicine 14(1):73–8, Copyright 1988, Alan R. Liss, Inc.

OCR for page 745
Environmental Medicine: Integrating a Missing Element into Medical Education Fig. 1. Floor plan and distribution of TDI concentration in air samples of the velcro tape manufacturing factory. Big black dots indicate the place where samples were taken. ▨ indicates the place where the adhesive is applied to the tape; indicates the place where the adhesive is heated and dried. found that the adhesive resin contained toluene diisocyanate (TDI), a well-known cause of occupational asthma [NIOSH, 1978; Chan-Yeung and Lam, 1986; NIOSH, 1977b]. Because TDI-induced occupational asthma has never, to our knowledge, been documented in Taiwan, this study was conducted to determine the etiology and prevalence rate of this outbreak of workers’ asthma. MATERIALS AND METHODS The factory has 45 employees and has been in operation since 1984. Most of the employees were young women (median age 22 years). The female to male ratio was 3.2:1. The employees’ turnover rate was high; the average length of employment was 9.2 months. We tried to interview and examine all employees. Air samples were taken by midget impingers at different locations in the factory and they analyzed for TDI concentrations by colorimetric methods [NIOSH, 1977a]. Pulmonary function tests (PFTs) [Ferris, 1978] were also performed on workers, using a portable spirometer (Chest autospiror-298), during a usual workday, after a 10-day holiday, and 5 months after the improvement of the workplace by effective isolation and ventilation control. All tests were done in the morning (between 8:30–10:30 AM) at the factory office to avoid across-shift functional deterioration. The factory was divided into three functional areas: the weaving area, where the tape is woven; the processing area, where the tape is dyed and the adhesive resin is applied; and the packaging/storage area. The three areas were connected through doors, with the packaging area in the middle of the other two (Fig. 1). A case of asthma or asthmatic bronchitis was defined as any worker who

OCR for page 746
Environmental Medicine: Integrating a Missing Element into Medical Education TABLE I. Incidence of Asthmatic Bronchitis Symptoms by Workplace and Air Concentration of Toluene Diisocyanate (TDI)* Workplace Air concentration of TDI (in ppm) Case Non-case Total Rate (%) Processing 0.047±0.054 11 2 13 84.6 Packaging/ Storage 0.021±0.006 3 5 8 37.5 Weaving 0.012±0.002 0 13 13 0.0 Total   14 20 34 41.2 *X2 Mantel-test for trend=18.6 (p<.001). developed symptoms of cough for more than 1 month and shortness of breath or wheezing for 1 month after working in this factory. Workers with a history of prior cardiovascular or pulmonary diseases, previous known exposure to pulmonary irritants, and previous smoking history were excluded from analysis. Mantel extension for the test of trend [Mantel, 1963] and paired Student’s t-test were performed to evaluate the statistical significance. RESULTS Completed interviews and physical examinations were obtained for 38 of 45 (84%) workers; of these, four workers were excluded because of a smoking history. Among the remaining 34 workers, 14 met the case definition for asthma or asthmatic bronchitis. The highest attack rate occurred among workers in the tape processing area and the lowest was in the weaving area. Four of 14 cases of asthma compared with none of the noncases had wheezing rales on chest examination (p<0.0001). All four cases with auscultatory findings worked in the tape processing area. Air samples collected from various locations in the factory revealed that TDI concentrations were highest in the tape processing area with a mean of 0.047±0.054 ppm (n=15), and lowest in the weaving area with a mean of 0.012±0.002 ppm (n=3). The packaging/storage area had intermediate levels of TDI with a mean of 0.021±0.006 ppm (n=3). A highly significant trend was noted between the increased concentration of TDI and the increased occurrence rate of asthma (Table I). Since some workers left the company after the 10-day holiday, we successfully performed pulmonary function tests before and after holiday on only 21 workers, at the factory office between 8:30–10:00 AM before the start of work. Workers in the processing area had the greatest changes in pre- and post exposure FEV1 and FVC (Table II). Based on the results of the investigation, we recommended that the factory install new ventilation hoods, improve the design of existing hoods, and isolate the process of applying TDI-containing adhesives to protect workers from TDI vapors. We also recommended the factory change the formula of the adhesive resin and substitute diphenyl methane diisocyanate (MDI) for TDI, because MDI has a higher vaporization temperature and a lower vaporization pressure [ACGIH, 1980]. Five months after these recommendations were implemented, workers were reexamined and air samplings were repeated. No worker complained of asthmalike symptoms. FEV1 and FVC measurements for 10 workers still employed at the time of follow-up

OCR for page 747
Environmental Medicine: Integrating a Missing Element into Medical Education TABLE II. Change in Pre- and Postexposure One-second Forced Expiratory Volume (FEV) and Forced Vital Capacity (FVC) Among Employees Classified by Workplace Workplace No. workers Change in FEV (mean±1 S.D., in ml) Change in FVC (mean±1 S.D., in ml) p-valuea Processing 9 −431±246   −334±279       p=0.035     p=N.S.   Packaging/storage 4 −118+102   −146±123   p<0.005     p=N.S.     p=N.S.   Weaving 8 +10±311   +36±145   aStudent’s t-test; N.S.=not significant. showed significant improvement in pulmonary function (Table III). The mean duration of employment of these workers before our examination was 7.7±4.6 months. Seven of 9 air samples showed undetectable concentrations of isocyanates; the other two samples were below 0.007 ppm at the processing area. DISCUSSION Diisocyanates are used quite extensively in many industries for manufacturing polyurethane resins of various physical properties, e.g., hard, flexible, or semirigid foams. They may cause irritation of eyes, respiratory tract, and skin. The irritation may be severe enough to produce bronchitis and pulmonary edema. It has been estimated that approximately 4.3–25% of workers exposed to an air level of .02 ppm TDI develop asthma. [Weill et al., 1981; Adams, 1975] Symptoms may develop weeks or months after exposure. Exposure to very low levels of TDI (<.005 ppm) may induce an asthmatic attack in individuals sensitized by previous exposure to TDI. Therefore, an IgE-mediated allergic mechanism has been postulated but not unequivocally confirmed as the cause of TDI-induced asthma [Chan-Yeung and Lam, 1986]. Another possible mechanism is through a pharmacologic reaction of the bronchus. In either case, the establishment of diagnosis may be through a bronchial provocation test [Pepys and Hutchcroft, 1975] or an epidemiological study. Because an epidemiologic approach can directly examine the workplace, we took this method and performed air measurements of TDI. The current threshold limit value (TLV) recommended by the American Conference of Governmental Industrial Hygienists is 0.005 ppm [ACGIH, 1986]. All 11 air samples originally taken in the processing area were above this level. The highest concentration measured, at the drying operation (Fig. 1), was 0.236 ppm, which was more than 47 times the TLV. The higher attack rates of asthmalike symptoms reported in our investigation may have been due to the difficulty in distinguishing true allergic cases from workers with other symptoms of pharmacologic reaction or pulmonary irritation, e.g., bronchitis, following exposure to high levels of TDI. We were able to show an objective reduction in pulmonary function for workers in areas with occasional high TDI concentrations. Both symptoms and pulmonary function tests improved after a period (10 days) away from the factory and also after improvements were made in the factory’s design and ventilation system. In fact, three of the four workers with clinically overt asthma went back to work without any symptoms. The fourth worker has not gone back to the factory, although she is currently asymptomatic and her lung function has returned to

OCR for page 748
Environmental Medicine: Integrating a Missing Element into Medical Education TABLE III. Improvement in Pulmonary Function Tests Among Employees Under Different Working Conditions*   Beginning of study (ml)   After 10-day holiday (ml)   5 months after recommendations (ml) FEV1 (mean±1 S.D.) 1978±588   2250±342   2422+377             p=0.048   p=0.004   FVC (mean±1 S.D.) 2605±366   2799±276   3025+347             p=0.004   p=0.002   *p-values calculated using paired Student’s t-test. within normal. Therefore, we concluded that both asthma and other symptoms of pulmonary irritation were due to occupational exposure to TDI, and that the improvement in the work environment was effective. Although some authors have reported that ventilatory functions may not fully recover among all sensitized workers after removal from TDI exposure [Adams, 1975; Weill et al., 1981], we did find a significant improvement of lung function among workers. Possible explanations for the discrepancy of these findings are: 1) many of our workers with symptoms of occupational asthma may not have been truly sensitized and developed symptoms simply because of the irritant effect of TDI; 2) our 10 workers had shorter durations of exposure to TDI, i.e., 7.7±4.6 months, which might only cause a more reversible effect. This investigation clearly illustrates the impact of an occupational health hazard in a factory. The prevalence of occupational diseases in Taiwan is unknown but is probably high given the rapid industrialization and increased use of many potentially hazardous chemicals in manufacturing in recent years. At present, governmental agencies responsible for monitoring occupational diseases are grossly underfunded and understaffed. This investigation illustrates not only that occupational health problems exist in Taiwan, but they can often be remedied with minimal cost to industry. The key to improving occupational health among workers in Taiwan and elsewhere is to establish better procedures for licensing and inspecting factories and to train physicians and industrial hygienists to conduct proper health hazard evaluations and implement environmental control measures. ACKNOWLEDGMENTS This study was supported by a special grant from the Department of Health, Executive Yuan, R.O.C. REFERENCES Adams WGF (1975): Long-term effects on the health of men engaged in the manufacture of toluene diisocyanate. Br J Industr Med 32:72–8. American Conference of Governmental Industrial Hygienists (ACGIH) (1980): “Documentation of the Threshold Limit Values.” Cincinnati: ACGIH Inc. 274–5, 401–2, 1–6(84).

OCR for page 749
Environmental Medicine: Integrating a Missing Element into Medical Education American Conference of Governmental Industrial Hygienists (ACGIH) (1986): “Threshold Limit Values for Chemical Substances in the Work Environment Adopted by ACGIH for 1986–7.” Cincinnati: ACGIH. Chan-Yeung M, Lam S (1986): State of the art: Occupational asthma. Am Rev Respir Dis 133:686–703. Ferris B (1978): Epidemiology standardization project. Am Rev Respir Dis 118(suppl):55–88. Mantel N (1963): Chi-square tests with one degree of freedom: Extensions of Mantel-Haenszel procedure. J Am Stat Assoc 58:690–700. National Institute for Occupational Safety and Health (NIOSH) (1978): “Criteria for a Recommended Standard: Occupational Exposure to Diisocyanates, publication 78–215.” U.S. Dept of Health, Education, and Welfare. National Institute for Occupational Safety and Health (NIOSH) (1977a): “NIOSH Manual of Analytic Methods.” U.S. Dept of Health, Education, and Welfare. 1:141–1. National Institute for Occupational Safety and Health (1977b): “Occupational diseases: A guide to their recognition. Publication No. 77–181.” Washington D.C.: U.S. Government Printing Office 233–5. Pepys J, Hutchcroft BJ (1975): State of the art: Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 112:335–65. Weill H, Butcher BT, Dharmarajan V, et al. (1981): “Respiratory and immunologic evaluation of isocyanate exposure in a new manufacturing plant.” NIOSH Publication No. 81–125. NIOSH Technical Report, Washington DC: U.S. Government Printing Office.

Representative terms from entire chapter:

air samples